A Phase II Clinical Study of ISC-hpNSC for the Treatment of Traumatic Brain Injury
Phase of Trial: Phase II
Latest Information Update: 10 Apr 2018
Price : $35 *
At a glance
- Drugs ISC-hpNSC (Primary)
- Indications Traumatic brain injuries
- Focus Therapeutic Use
- 10 Apr 2018 According to an International Stem Cell Corporation media release, the company expects to initiate this phase II study in 2018.
- 22 Sep 2017 New trial record
- 20 Sep 2017 According to an International Stem Cell Corporation media release, the company is planning to file a Clinical Trial Notification with the Australian TGA.